
Louise Wang Zhiying Humphrey
Supervisory Patent Examiner (ID: 4289, Phone: (571)272-5543 , Office: P/1657 )
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1657, 1648 |
| Total Applications | 627 |
| Issued Applications | 267 |
| Pending Applications | 54 |
| Abandoned Applications | 312 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7060989
[patent_doc_number] => 20050003350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Novel methods for HIV sequencing and genotyping'
[patent_app_type] => utility
[patent_app_number] => 10/915998
[patent_app_country] => US
[patent_app_date] => 2004-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5698
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20050003350.pdf
[firstpage_image] =>[orig_patent_app_number] => 10915998
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/915998 | Novel methods for HIV sequencing and genotyping | Aug 9, 2004 | Abandoned |
Array
(
[id] => 7252438
[patent_doc_number] => 20050074854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-07
[patent_title] => 'Glycosylated specificity exchangers'
[patent_app_type] => utility
[patent_app_number] => 10/913754
[patent_app_country] => US
[patent_app_date] => 2004-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 20268
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20050074854.pdf
[firstpage_image] =>[orig_patent_app_number] => 10913754
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/913754 | Glycosylated specificity exchangers | Aug 5, 2004 | Issued |
Array
(
[id] => 7326797
[patent_doc_number] => 20040253210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-16
[patent_title] => 'Adenovirus type7 vectors'
[patent_app_type] => new
[patent_app_number] => 10/487974
[patent_app_country] => US
[patent_app_date] => 2004-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 8883
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20040253210.pdf
[firstpage_image] =>[orig_patent_app_number] => 10487974
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/487974 | Adenovirus type7 vectors | Aug 4, 2004 | Abandoned |
Array
(
[id] => 5028914
[patent_doc_number] => 20070270361
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-22
[patent_title] => 'Sars Nucleic Acids, Proteins, Vaccines, and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 10/565314
[patent_app_country] => US
[patent_app_date] => 2004-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 18094
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20070270361.pdf
[firstpage_image] =>[orig_patent_app_number] => 10565314
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/565314 | Sars Nucleic Acids, Proteins, Vaccines, and Uses Thereof | Aug 3, 2004 | Abandoned |
Array
(
[id] => 6918057
[patent_doc_number] => 20050095618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-05
[patent_title] => 'Compositions and methods for diagnosing and treating severe acute respiratory syndrome (SARS)'
[patent_app_type] => utility
[patent_app_number] => 10/901744
[patent_app_country] => US
[patent_app_date] => 2004-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 23297
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20050095618.pdf
[firstpage_image] =>[orig_patent_app_number] => 10901744
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/901744 | Compositions and methods for diagnosing and treating severe acute respiratory syndrome (SARS) | Jul 27, 2004 | Issued |
Array
(
[id] => 7254862
[patent_doc_number] => 20050075292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-07
[patent_title] => 'Compositions and methods for treating HIV infections'
[patent_app_type] => utility
[patent_app_number] => 10/891825
[patent_app_country] => US
[patent_app_date] => 2004-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 26348
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0075/20050075292.pdf
[firstpage_image] =>[orig_patent_app_number] => 10891825
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/891825 | Compositions of beta-defensin inducing agents | Jul 13, 2004 | Issued |
Array
(
[id] => 6938990
[patent_doc_number] => 20050112553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Mammalian genes involved in viral infection and tumor suppression'
[patent_app_type] => utility
[patent_app_number] => 10/877807
[patent_app_country] => US
[patent_app_date] => 2004-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16196
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20050112553.pdf
[firstpage_image] =>[orig_patent_app_number] => 10877807
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/877807 | Mammalian genes involved in viral infection and tumor suppression | Jun 24, 2004 | Abandoned |
Array
(
[id] => 4921515
[patent_doc_number] => 20080069830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-20
[patent_title] => 'Dna Sequences, Peptides, Antibodies and Vaccines for Prevention and Treatment of Sars'
[patent_app_type] => utility
[patent_app_number] => 10/562164
[patent_app_country] => US
[patent_app_date] => 2004-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7925
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20080069830.pdf
[firstpage_image] =>[orig_patent_app_number] => 10562164
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/562164 | Dna Sequences, Peptides, Antibodies and Vaccines for Prevention and Treatment of Sars | Jun 23, 2004 | Abandoned |
Array
(
[id] => 9046450
[patent_doc_number] => 08541003
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-24
[patent_title] => 'Vectors expressing SARS immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using'
[patent_app_type] => utility
[patent_app_number] => 10/873424
[patent_app_country] => US
[patent_app_date] => 2004-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 56
[patent_figures_cnt] => 89
[patent_no_of_words] => 27303
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10873424
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/873424 | Vectors expressing SARS immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using | Jun 20, 2004 | Issued |
Array
(
[id] => 4726742
[patent_doc_number] => 20080206283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'Vaccine Against Sars'
[patent_app_type] => utility
[patent_app_number] => 10/561315
[patent_app_country] => US
[patent_app_date] => 2004-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 16150
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0206/20080206283.pdf
[firstpage_image] =>[orig_patent_app_number] => 10561315
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/561315 | Vaccine Against Sars | Jun 16, 2004 | Abandoned |
Array
(
[id] => 7317493
[patent_doc_number] => 20040224311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Method for measuring anti-protease resistance of HIV-2 in a patient'
[patent_app_type] => new
[patent_app_number] => 10/865889
[patent_app_country] => US
[patent_app_date] => 2004-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4887
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20040224311.pdf
[firstpage_image] =>[orig_patent_app_number] => 10865889
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/865889 | Method for measuring resistance of a patient HIV-2 to protease inhibitors | Jun 13, 2004 | Issued |
Array
(
[id] => 7060988
[patent_doc_number] => 20050003349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'High titer recombinant influenza viruses for vaccines and gene therapy'
[patent_app_type] => utility
[patent_app_number] => 10/855875
[patent_app_country] => US
[patent_app_date] => 2004-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14262
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20050003349.pdf
[firstpage_image] =>[orig_patent_app_number] => 10855875
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/855875 | High titer recombinant influenza viruses for vaccines and gene therapy | May 26, 2004 | Issued |
Array
(
[id] => 872707
[patent_doc_number] => 07361747
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-04-22
[patent_title] => 'Isolation and characterization of the precursor virus of human SARS virus: SARS-associated corona virus-like virus'
[patent_app_type] => utility
[patent_app_number] => 10/852357
[patent_app_country] => US
[patent_app_date] => 2004-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 82
[patent_figures_cnt] => 9
[patent_no_of_words] => 20726
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/361/07361747.pdf
[firstpage_image] =>[orig_patent_app_number] => 10852357
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/852357 | Isolation and characterization of the precursor virus of human SARS virus: SARS-associated corona virus-like virus | May 23, 2004 | Issued |
Array
(
[id] => 7123210
[patent_doc_number] => 20050015039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-20
[patent_title] => 'Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein'
[patent_app_type] => utility
[patent_app_number] => 10/851637
[patent_app_country] => US
[patent_app_date] => 2004-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 34141
[patent_no_of_claims] => 130
[patent_no_of_ind_claims] => 31
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20050015039.pdf
[firstpage_image] =>[orig_patent_app_number] => 10851637
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/851637 | Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein | May 23, 2004 | Issued |
Array
(
[id] => 5666573
[patent_doc_number] => 20060171923
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-03
[patent_title] => 'Methods of identifying modulators of human retrovirus replication'
[patent_app_type] => utility
[patent_app_number] => 10/849567
[patent_app_country] => US
[patent_app_date] => 2004-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 9341
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20060171923.pdf
[firstpage_image] =>[orig_patent_app_number] => 10849567
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/849567 | Methods of identifying modulators of human retrovirus replication | May 17, 2004 | Issued |
Array
(
[id] => 6930795
[patent_doc_number] => 20050281829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => 'Fc chimeric proteins with anti-HIV drugs'
[patent_app_type] => utility
[patent_app_number] => 10/841956
[patent_app_country] => US
[patent_app_date] => 2004-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 20018
[patent_no_of_claims] => 92
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20050281829.pdf
[firstpage_image] =>[orig_patent_app_number] => 10841956
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/841956 | Fc chimeric proteins with anti-HIV drugs | May 5, 2004 | Abandoned |
Array
(
[id] => 823158
[patent_doc_number] => 07404956
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-07-29
[patent_title] => 'Immunoglobulin chimeric monomer-dimer hybrids'
[patent_app_type] => utility
[patent_app_number] => 10/841250
[patent_app_country] => US
[patent_app_date] => 2004-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 40
[patent_no_of_words] => 36926
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/404/07404956.pdf
[firstpage_image] =>[orig_patent_app_number] => 10841250
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/841250 | Immunoglobulin chimeric monomer-dimer hybrids | May 5, 2004 | Issued |
Array
(
[id] => 482167
[patent_doc_number] => 07220554
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-05-22
[patent_title] => 'Methods for identifying inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/838770
[patent_app_country] => US
[patent_app_date] => 2004-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 32
[patent_no_of_words] => 42703
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/220/07220554.pdf
[firstpage_image] =>[orig_patent_app_number] => 10838770
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/838770 | Methods for identifying inhibitors | May 2, 2004 | Issued |
Array
(
[id] => 7098570
[patent_doc_number] => 20050131029
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => 'Immunophilin ligand treatment of antiretroviral toxic neuropathy'
[patent_app_type] => utility
[patent_app_number] => 10/836517
[patent_app_country] => US
[patent_app_date] => 2004-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10171
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20050131029.pdf
[firstpage_image] =>[orig_patent_app_number] => 10836517
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/836517 | Immunophilin ligand treatment of antiretroviral toxic neuropathy | Apr 29, 2004 | Abandoned |
Array
(
[id] => 7402301
[patent_doc_number] => 20040175365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-09
[patent_title] => 'Methods and reagents for vaccination which generate a CD8 T cell immune response'
[patent_app_type] => new
[patent_app_number] => 10/833439
[patent_app_country] => US
[patent_app_date] => 2004-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 19914
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20040175365.pdf
[firstpage_image] =>[orig_patent_app_number] => 10833439
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/833439 | Methods and reagents for immunization which generate a CD8 T cell immune response | Apr 27, 2004 | Issued |